Next Article in Journal
Rabies in Romania—Editorial Comment
Previous Article in Journal
Recent Advances in the Diagnosis of Mycobacterium tuberculosis
 
 
GERMS is published by MDPI from Volume 15 Issue 4 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the former publisher Infection Science Forum.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Talactoferrin

by
Hilary Denis Solomons
Hilary Denis Solomons, MB BCh, M Med Hematology, Pathology, University of the Witwatersrand, P.O. Box 64203, Highlands North 2037, South Africa
Submission received: 1 July 2012 / Revised: 1 August 2012 / Accepted: 19 August 2012 / Published: 1 September 2012
Lactoferrin is a natural globular protein with a molecular atomic mass of 80 kD. It is found in milk and many mucosal secretions such as tears and it belongs to the transferring proteins (transferrin [1], melanotransferrin, ovotransferrin, etc.) showing a high affinity for iron (ferric state).
Talactoferrin, an orally-administered recombinant human lactoferrin, can be produced by the fungus Aspergillus niger var. awamori [2] and has potential antineoplastic, antibacterial and immunomodulating activities. Recombinant human lactoferrin can be produced in various plant systems (e.g., tobacco, potato, rice etc.), animal systems (transgenic mice, cows, rabbits, etc.), viruses, fungi or cell cultures [2], displaying somewhat different properties according to the expression system used.
When administered topically, talactoferrin alpha binds to keratinocytes and fibroblasts and enhancesthe production of cytokines and key repair immunomodulatory factors such as interleukins IL-8, IL-6, macrophage inflammatory protein-1 alpha and tumor necrosis factor alpha [3].
Talactoferrin also appears to have antibacterial properties and it has been recently evaluated as oral therapy in severe sepsis [3,4,5]. Bovine lactoferrin has been reported to reduce the incidence of early onset sepsis when administered orally, as a supplement, either alone or with the probiotic Lactobacillus rhamnosus GG,in very-low birth weight premature infants (under 1500 g) [2,6].
The effects of orally-administered talactoferrin in cancer or in sepsis [7] are dependent on its transportation into the gut-associated lymphoid tissue (GALT), where it is responsible for recruiting and inducing the maturation of circulating immature dendritic cells bearing tumour antigens. Consequently, lymphoid effector cells induce systemic immune responses through natural killer (NK) cells and cytotoxic T lymphocytes (CTL) thus countering the local tumor-mediated immunosuppression [8].
In conclusion, talactoferrin is an interesting antineoplastic agent which could also be useful in wound healing and, potentially in severe infections. Phase III studies are needed to clarify its potential role in severe sepsis.

References

  1. Solomons, H. Carbohydrate deficient transferrin and alcoholism. GERMS 2012, 2, 75–8. [Google Scholar] [CrossRef] [PubMed]
  2. Conesa, C.; Calvo, M.; Sanchez, L. Recombinant human lactoferrin: a valuable protein for pharmaceutical products and functional foods. Biotechnol Adv 2010, 28, 831–8. [Google Scholar] [CrossRef] [PubMed]
  3. Engelmayer, J.; Blezinger, P.; Varadhachary, A. Talactoferrin stimulates wound healing with modulation of inflammation. J Surg Res 2008, 149, 278–86. [Google Scholar] [CrossRef] [PubMed]
  4. Fernebro, J. Fighting bacterial infections-future treatment options. Drug Resist Updat 2011, 14, 125–39. [Google Scholar] [CrossRef] [PubMed]
  5. Huttunen, R.; Aittoniemi, J. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J Infect 2011, 63, 407–19. [Google Scholar] [CrossRef]
  6. Manzoni, P.; Rinaldi, M.; Cattani, S.; et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009, 302, 1421–8. [Google Scholar] [CrossRef] [PubMed]
  7. Li, S.; Bao, H.; Han, L.; Liu, L. Effects of propofol on early and late cytokines in lipopolysaccharide-induced septic shock in rats. J Biomed Res 2010, 24, 389–94. [Google Scholar] [CrossRef]
  8. National Cancer Institute at the National Institute of Health. NCI Drug Dictionary. Available online: http://www.cancer.gov/drug dictionary?cdrid=394101 (accessed on 11 August 2012).

Share and Cite

MDPI and ACS Style

Solomons, H.D. Talactoferrin. GERMS 2012, 2, 121. https://doi.org/10.11599/germs.2012.1022

AMA Style

Solomons HD. Talactoferrin. GERMS. 2012; 2(3):121. https://doi.org/10.11599/germs.2012.1022

Chicago/Turabian Style

Solomons, Hilary Denis. 2012. "Talactoferrin" GERMS 2, no. 3: 121. https://doi.org/10.11599/germs.2012.1022

APA Style

Solomons, H. D. (2012). Talactoferrin. GERMS, 2(3), 121. https://doi.org/10.11599/germs.2012.1022

Article Metrics

Back to TopTop